Category: Pricing Strategies
-
The TPP Guide: Unlocking Market Access in Biopharma
In the fast-paced business of biopharma, the journey from product discovery to market access is fraught with complexity. A Target Product Profile (TPP) serves not just as a blueprint for development but as a strategic compass across functions, including market access and pricing. As seasoned professionals know, a TPP’s value extends beyond clinical development into… Read more
-
Understanding Drug Pricing Strategies with GLP-1 Agents
In the dynamic world of biopharma, understanding drug pricing strategies is more than just an academic exercise—it’s a crucial element of market success. Glucagon-like peptide 1 (GLP-1) agonists1 such as Novo Nordisk’s Ozempic, Novo Nordisk’s Wegovy, Eli Lilly’s Mounjaro, and Eli Lilly’s Zepbound offer a set of case studies that are helpful in illustrating common… Read more
-
Understanding Drug Pricing: A Primer for Biopharma Professionals
Imagine venturing into a realm where scientific innovation collides with economic principles, where the quest to alleviate suffering balances with financial realities. Welcome to the world of drug pricing. In the biopharma sector, understanding the nuances of drug pricing isn’t just a necessity—it’s an art form. As we delve into this realm, we unravel the… Read more
-
The Pillars of an Effective Market Access Strategy
Market access strategy is the integrated set of choices that ensure a drug, biologic, or medical device is available and can be efficiently and sustainably utilized by those who need it. Effective execution requires a symphony of activities across diverse functions within a biopharma organization and often extends into collaboration with external stakeholders. Here we… Read more